Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Archi Indonesia Tbk (ARCI) vs Merck Tbk. (MERK) Price & Performance

Archi Indonesia Tbk
Merck Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Archi Indonesia Tbk vs Merck Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp930 (market cap 24.86T, 21.8M 24h volume), while Merck Tbk. trades at Rp3,730 (market cap 1.65T, 60.4K 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 15.1× Merck Tbk.'s market cap, and Archi Indonesia Tbk is more actively traded (21.8M versus 60.4K). Which is the better fit depends on your goals.

ARCIMERK
Market Cap
24.86T1.65T
Volume
21.8M60.4K
Lot
218.04K604
Turnover
20.81B223.42M
Average Price
954.513,698.92
Value
20.81B223.42M
Indicative Equilibrium Price
930
Indicative Equilibrium Volume
5.48K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ARCI
View details
MERK
View details

About Archi Indonesia Tbk

PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.

Read more on ARCI

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK